Detalhe da pesquisa
1.
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Nat Genet
; 31(1): 55-9, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11967536
2.
MUTYH gene variants and breast cancer in a Dutch casecontrol study.
Breast Cancer Res Treat
; 134(1): 219-27, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297469
3.
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.
Breast Cancer Res Treat
; 132(2): 439-48, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21614566
4.
Association of rare MSH6 variants with familial breast cancer.
Breast Cancer Res Treat
; 123(2): 315-20, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924528
5.
Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Breast Cancer Res Treat
; 124(3): 635-41, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20191381
6.
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.
Breast Cancer Res Treat
; 121(1): 53-64, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19593635
7.
Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.
Cancer Epidemiol Biomarkers Prev
; 18(1): 230-4, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19124502
8.
CHEK2 1100delC and male breast cancer in the Netherlands.
Breast Cancer Res Treat
; 116(2): 397-400, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18759107
9.
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
Breast Cancer Res Treat
; 113(2): 285-91, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18297428
10.
CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.
Clin Cancer Res
; 14(15): 4989-94, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18676774
11.
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
Cancer Res
; 66(1): 41-5, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16397213
12.
A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers.
Cancer Epidemiol Biomarkers Prev
; 15(12): 2542-5, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17164383
13.
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Cancer Res
; 64(3): 840-3, 2004 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14871810
14.
Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy.
Open Heart
; 1(1): e000116, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25332820
15.
Discovering moderate-risk breast cancer susceptibility genes.
Curr Opin Genet Dev
; 20(3): 268-76, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20346647
16.
MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.
Breast Cancer Res Treat
; 104(2): 153-7, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17080308
17.
Exon expression arrays as a tool to identify new cancer genes.
PLoS One
; 3(8): e3007, 2007 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18688287
18.
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
Breast Cancer Res Treat
; 99(1): 97-101, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16541312
19.
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.
Am J Hum Genet
; 72(5): 1308-14, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12690581
20.
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.
Am J Hum Genet
; 72(4): 1023-8, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12610780